You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 381 SUPLEXA, a multimodal autologous cellular therapy, shows immunomodulatory behavior in cancer patients consistent with improved anti-tumor immune function

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
381 SUPLEXA, a multimodal autologous cellular therapy, shows immunomodulatory behavior in cancer patients consistent with improved anti-tumor immune function

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023178011
Dec 202367013
Jan 20242603
Feb 20243203
Mar 20242605
Apr 20241804
May 20244005
Jun 20241602
Jul 20247603
Aug 20243801
Sep 20242201
Oct 20242807
Nov 20243006
Dec 20241404
Jan 202550012
Feb 2025406
Mar 2025005
Apr 2025002
May 2025004
Jun 2025003
Total6650100